Sept. 27, 2021
Prime Therapeutics welcomes Chris Knibb as Chief Financial Officer
Promotes Dave Schlett to executive vice president.
Aug. 11, 2021
Telemedicine schemes contribute to a 60% increase in reported false claims during pandemic year 2020.
May 26, 2021
MedDrive to tackle the toughest challenges facing growing medical Rx drug spend, harness the multi-billion-dollar potential savings in biosimilar market.
May 11, 2021
Largest statin use improvement found when program is coupled with proactive pharmacist outreach.
May 6, 2021
Ken Paulus signs CEO Action for Diversity & Inclusion pledge
Prime Therapeutics commits to advancing diversity and inclusion efforts in the workplace.
May 5, 2021
Prime Therapeutics Ups Its Predictive Analytics Game with Differentiated Integrated Data Platform
Insights+ informs smarter business decisions, helps improve clinical outcomes driven by data trends, predictions.
April 26, 2021
Two acts are a much-needed boost to help normalize use of biosimilars, just as generics were normalized years ago.
April 26, 2021
Prime Therapeutics welcomes new client success leader
DeZearn to lead our client teams and help ensure Prime’s client relationships are collaborative, accountable, responsive and aligned.
April 13, 2021
Prime Therapeutics’ Omaha office transitions to fully remote workforce
Changes made due to COVID-19 pandemic allows for long-term convenience, flexibility.
April 12, 2021
A real-world look at all treatment costs for large B-cell lymphoma illustrates need for close financial management.
April 7, 2021
Prime researchers analyzed real-world autoimmune conditions drug use patterns including MS specialty therapies.
March 25, 2021
Pharmacies serving commercial and health insurance marketplace members will also be paid at the new CMS rate.